Emerging Targets in Kidney Cancer: Opportunities for Drug Development

H&O  How common is kidney cancer? WS  Kidney cancer, also known as renal cancer, is an unusual—although perhaps not rare—cancer. There are approximately 76,000 new cases […]

Combined Blockade of Vascular Endothelial Growth Factor and Programmed Death 1 Pathways in Advanced Kidney Cancer

  Abstract: Targeted and immune-based therapies have improved outcomes in advanced kidney cancer, yet novel strategies are needed to extend the duration of these benefits and […]

Genetic Conditions Associated With a Predisposition to Kidney Cancer

  Based on a presentation by W. Marston Linehan, MD, at the ASCO Genitourinary Cancers Symposium  Scientists have identified at least 13 genes that pre­dispose patients […]

Kidney Cancer News

  Cancer Vaccine Fails to Improve Survival in Metastatic Renal Cell Carcinoma The addition of the IMA901 multipeptide cancer vaccine to sunitinib (Sutent, Pfizer) did not […]

Kidney Cancer News

Clinical Advances in Hematology & Oncology October 2016, Volume 14, Issue 10   High Body Mass Index Linked to Improved Survival in Metastatic Renal Carcinoma High […]